Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IDEAYA Biosciences (IDYA) Return on Sales (2020 - 2025)

IDEAYA Biosciences (IDYA) has disclosed Return on Sales for 6 consecutive years, with 8.7% as the latest value for Q4 2025.

  • Quarterly Return on Sales rose 1190.0% to 8.7% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.73% through Dec 2025, up 4598.0% year-over-year, with the annual reading at 0.73% for FY2025, 4598.0% up from the prior year.
  • Return on Sales hit 8.7% in Q4 2025 for IDEAYA Biosciences, down from 0.52% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.52% in Q3 2025 to a low of 57.31% in Q3 2024.
  • Historically, Return on Sales has averaged 13.39% across 5 years, with a median of 6.39% in 2021.
  • Biggest five-year swings in Return on Sales: tumbled -5314bps in 2024 and later skyrocketed 5783bps in 2025.
  • Year by year, Return on Sales stood at 6.2% in 2021, then dropped by -6bps to 6.57% in 2022, then plummeted by -63bps to 10.69% in 2023, then tumbled by -93bps to 20.59% in 2024, then surged by 58bps to 8.7% in 2025.
  • Business Quant data shows Return on Sales for IDYA at 8.7% in Q4 2025, 0.52% in Q3 2025, and 54.89% in Q2 2025.